GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Additional Paid-In Capital

Longevity Biomedical (Longevity Biomedical) Additional Paid-In Capital : $0.00 Mil(As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Additional Paid-In Capital?


Longevity Biomedical Additional Paid-In Capital Historical Data

The historical data trend for Longevity Biomedical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Additional Paid-In Capital Chart

Longevity Biomedical Annual Data
Trend
Additional Paid-In Capital

Longevity Biomedical Semi-Annual Data
Additional Paid-In Capital

Longevity Biomedical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Longevity Biomedical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Additional Paid-In Capital
Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Website
https://www.longevitybiomedical.com
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines